Position in SCLX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$7
+$1 QoQ
Shares Held
1
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 23 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TSFG, LLC holds $36,697,261 across 15 Drug Manufacturers - General names. SCLX ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
134,486 | $33,842,057 | |
| 2 | LLY |
ELI LILLY & Co
|
962 | $1,153,851 | |
| 3 | JNJ |
Johnson & Johnson
|
2,996 | $760,894 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,866 | $239,781 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,324 | $167,274 | |
| 6 | AMGN |
Amgen Inc
|
330 | $119,499 | |
| 7 | PFE |
Pfizer Inc
|
4,874 | $117,365 | |
| 8 | AZN |
Astrazeneca PLC
|
573 | $108,652 |
All Filings in SCLX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7 | 1 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $6 | 1 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $12 | 1 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $19 | 1 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $5 | 1 | Shares | Sole | 2025-08-05 | |
| No filing history on record for this holder in this stock. | ||||||